Association between de novo lipogenesis susceptibility genes and coronary artery disease

被引:5
作者
Simons, Pomme I. H. G. [1 ,2 ,3 ]
Valkenburg, Olivier [4 ]
Stehouwer, Coen D. A. [2 ,3 ,5 ]
Brouwers, Martijn C. G. J. [1 ,3 ,6 ]
机构
[1] Maastricht Univ Med Ctr, Dept Internal Med, Div Endocrinol & Metab Dis, Maastricht, Netherlands
[2] Maastricht Univ, Lab Metab & Vasc Med, Maastricht, Netherlands
[3] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands
[4] Maastricht Univ Med Ctr, Dept Reprod Med, Maastricht, Netherlands
[5] Maastricht Univ Med Ctr, Dept Internal Med, Div Gen Internal Med, Maastricht, Netherlands
[6] Maastricht Univ Med Ctr, Dept Internal Med, Div Endocrinol & Metab Dis, POB 5800, NL-6202 Maastricht, Netherlands
关键词
de novo lipogenesis; Coronary artery disease; Fatty acids; Non-alcoholic fatty liver disease; Genetics; FATTY LIVER-DISEASE; HEART-DISEASE; P446L VARIANT; ACIDS; RISK; PATHWAY; LOCI;
D O I
10.1016/j.numecd.2022.09.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Coronary artery disease (CAD) is the principal cause of death in individuals with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to use ge-netic epidemiology to study the association between de novo lipogenesis (DNL), one of the major pathways leading to NAFLD, and CAD risk.Methods and results: DNL susceptibility genes were used as instruments and selected using three approaches: 1) genes that are associated with both high serum triglycerides and low sex hormone-binding globulin, both downstream consequences of DNL (unbiased approach), 2) genes that have a known role in DNL (biased approach), and 3) genes that have been associated with serum fatty acids, used as a proxy of DNL. Gene-CAD effect estimates were retrieved from the meta-analysis of CARDIoGRAM and the UK Biobank (-76014 cases and-264785 controls). Effect estimates were clustered using a fixed-effects meta-analysis. Twenty-two DNL susceptibil-ity genes were identified by the unbiased approach, nine genes by the biased approach and seven genes were associated with plasma fatty acids. Clustering of genes selected in the unbiased and biased approach showed a statistically significant association with CAD (OR:1.016, 95%CI:1.012; 1.020 and OR:1.013, 95%CI:1.007; 1.020, respectively), while clustering of fatty acid genes did not (OR:1.004, 95%CI:0.996-1.011). Subsequent exclusion of potential influential outliers did reveal a statistically significant association (OR:1.009, 95%CI:1.000; 1.018).Conclusions: DNL susceptibility genes are associated with an increased risk of CAD. These find-ings suggest that DNL may be involved in the pathogenesis of CAD and favor further develop-ment of strategies that target NAFLD through DNL.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:2883 / 2889
页数:7
相关论文
共 43 条
  • [1] Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
    Adams, Leon A.
    Anstee, Quentin M.
    Tilg, Herbert
    Targher, Giovanni
    [J]. GUT, 2017, 66 (06) : 1138 - 1153
  • [2] Genetic Determinants of Lipids and Cardiovascular Disease Outcomes A Wide-Angled Mendelian Randomization Investigation
    Allara, Elias
    Morani, Gabriele
    Carter, Paul
    Gkatzionis, Apostolos
    Zuber, Verena
    Foley, Christopher N.
    Rees, Jessica M. B.
    Mason, Amy M.
    Bell, Steven
    Gill, Dipender
    Lindstrom, Sara
    Butterworth, Adam S.
    Di Angelantonio, Emanuele
    Peters, James
    Burgess, Stephen
    [J]. CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2019, 12 (12): : 543 - 551
  • [3] The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
    Beer, Nicola L.
    Tribble, Nicholas D.
    McCulloch, Laura J.
    Roos, Charlotta
    Johnson, Paul R. V.
    Orho-Melander, Marju
    Gloyn, Anna L.
    [J]. HUMAN MOLECULAR GENETICS, 2009, 18 (21) : 4081 - 4088
  • [4] Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
    Brouwers, Martijn C. G. J.
    Simons, Nynke
    Stehouwer, Coen D. A.
    Isaacs, Aaron
    [J]. DIABETOLOGIA, 2020, 63 (02) : 253 - 260
  • [5] Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease
    Brouwers, Martijn C. G. J.
    Simons, Nynke
    Stehouwer, Coen D. A.
    Koek, Ger H.
    Schaper, Nicolaas C.
    Isaacs, Aaron
    [J]. HEPATOLOGY COMMUNICATIONS, 2019, 3 (04) : 587 - 596
  • [6] Modulation of Glucokinase Regulatory Protein: A Double-Edged Sword?
    Brouwers, Martijn C. G. J.
    Jacobs, Chantal
    Bast, Aalt
    Stehouwer, Coen D. A.
    Schaper, Nicolaas C.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2015, 21 (10) : 583 - 594
  • [7] ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
    Calle, Roberto A.
    Amin, Neeta B.
    Carvajal-Gonzalez, Santos
    Ross, Trenton T.
    Bergman, Arthur
    Aggarwal, Sudeepta
    Crowley, Collin
    Rinaldi, Anthony
    Mancuso, Jessica
    Aggarwal, Naresh
    Somayaji, Veena
    Inglot, Malgorzata
    Tuthill, Theresa A.
    Kou, Kou
    Boucher, Magalie
    Tesz, Greg
    Dullea, Robert
    Bence, Kendra K.
    Kim, Albert M.
    Pfefferkorn, Jeffrey A.
    Esler, William P.
    [J]. NATURE MEDICINE, 2021, 27 (10) : 1836 - +
  • [8] Mendelian randomization: genetic anchors for causal inference in epidemiological studies
    Davey Smith, George
    Hemani, Gibran
    [J]. HUMAN MOLECULAR GENETICS, 2014, 23 : R89 - R98
  • [9] Variation in FTO contributes to childhood obesity and severe adult obesity
    Dina, Christian
    Meyre, David
    Gallina, Sophie
    Durand, Emmanuelle
    Koerner, Antje
    Jacobson, Peter
    Carlsson, Lena M. S.
    Kiess, Wieland
    Vatin, Vincent
    Lecoeur, Cecile
    Delplanque, Jerome
    Vaillant, Emmanuel
    Pattou, Francois
    Ruiz, Juan
    Weill, Jacques
    Levy-Marchal, Claire
    Horber, Fritz
    Potoczna, Natascha
    Hercberg, Serge
    Le Stunff, Catherine
    Bougneres, Pierre
    Kovacs, Peter
    Marre, Michel
    Balkau, Beverley
    Cauchi, Stephane
    Chevre, Jean-Claude
    Froguel, Philippe
    [J]. NATURE GENETICS, 2007, 39 (06) : 724 - 726
  • [10] Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease
    Diraison, F
    Moulin, P
    Beylot, M
    [J]. DIABETES & METABOLISM, 2003, 29 (05) : 478 - 485